133046-47-6 Usage
General Description
[2-(Trifluoromethyl)-1,3-thiazol-4-yl]methanol is a chemical compound with the molecular formula C6H6F3NOS. It is a derivative of thiazole, which is a heterocyclic compound containing a five-membered ring with sulfur and nitrogen atoms. The addition of a trifluoromethyl group to the thiazole ring provides unique properties and potential applications in pharmaceuticals and agrochemicals. The presence of a hydroxyl group also makes [2-(Trifluoromethyl)-1,3-thiazol-4-yl]methanol a versatile intermediate for the synthesis of other compounds. Due to its structural features and potential applications, this chemical compound is of interest to researchers in the fields of organic chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 133046-47-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,0,4 and 6 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 133046-47:
(8*1)+(7*3)+(6*3)+(5*0)+(4*4)+(3*6)+(2*4)+(1*7)=96
96 % 10 = 6
So 133046-47-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H4F3NOS/c6-5(7,8)4-9-3(1-10)2-11-4/h2,10H,1H2
133046-47-6Relevant articles and documents
PAR4 AGONIST PEPTIDES
-
Page/Page column, (2013/11/06)
The present invention provides PAR4 agonist peptides. These peptides are useful for developing robust PAR4 receptor assays.
2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1)
-
Page/Page column 47, (2008/06/13)
The use of a compound of formula (I): for the manufacture of a medicament for the treatment of conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1, also known as TRPV1).
BICYCLIC PYRIMIDIN-4-(3H)-ONES AND ANALOGUES AND DERIVATIVES THEREOF WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1)
-
Page/Page column 51, (2010/02/12)
Compounds of formula (I); which are useful as therapeutic compounds, particularly in the treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1).